Search Results 1411-1420 of 13319 for monoclonal antibody

1. A Study To Investigate Intravenous Tocilizumab In Patients With Moderate-to-Severe COVID-19 Pneumonia (Enrolling By Invitation Only) - Mayo Clinic

   Known severe allergic reactions to TCZ or other monoclonal antibodies;; Active TB infection;; Suspected active bacterial, fungal, viral, or other infection ...

2. Medical Research & Education - Mayo Clinic News Network

   Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...

3. Immune globulin-stwk (intravenous route) - Side effects & uses - Mayo Clinic

   Description. Immune globulin-stwk injection contains antibodies that make your immune system stronger. It is used for patients who have primary humoral ...

4. STI-3031 Through Sofusa DoseConnect For Treatment Of Intransit Melanoma - Mayo Clinic

   History of severe hypersensitivity reactions to other monoclonal antibodies or known hypersensitivity to the study intervention or its excipients, indocyanine ...

5. Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) With Avelumab In Muscle Invasive Bladder Cancer - Mayo Clinic

   Patients who have received the last administration of an anti-cancer therapy including chemotherapy, immunotherapy, and monoclonal ... monoclonal antibodies (NCI ...

6. A Study Investigating the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

   History of severe allergic or anaphylactic reactions to humanized or murine monoclonal antibodies or known sensitivity or allergy to murine products.

7. A Study Of Durvalumab In Combination With R-CHOP Or Lenalidomide Plus R-CHOP In Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Prior use of lenalidomide, or monoclonal antibodies against CTLA-4, PD-1, or PD-L1. High risk of developing thromboembolic events, who are unwilling to take ...

8. Clinical trials - Oncology (Medical)

   Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...

9. Breast Cancer Biomarker Sample Collection For The DtectDx V2 Assay Proof Of Concept Protocol - Mayo Clinic

   ... antibodies in your blood samples. The biomarker and antibody results along with your personal medical profile will be evaluated to determine your risk for ...

10. Study Assessing Safety And Efficacy Of Combination Of BL-8040 And Pembrolizumab In Metastatic Pancreatic Cancer Patients (COMBAT/KEYNOTE-202) - Mayo Clinic

    Has had a prior anti-cancer monoclonal antibody within 4 weeks prior to ... Has a known history of HIV (HIV 1/2 antibodies). Has known active Hepatitis ...